News
Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer A combination of molecular-targeted therapy and hormonal therapy may be the most promising area of research for those seeking an effective treatment for ovarian cancer, according to a new review in the International Journal of Gynecological Cancer.
|